PKL-021

N/A

Report date: 2022/08/09 15:34:46
NME

Base Information

Drug NamePKL-021
Drug Alias NamePKL-021
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMatrix metalloproteinase 9 inhibitors
TargetsMatrix metalloproteinase 9
Therapy Area/IndicationsEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPoland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPikralida SP ZOO
China Registration ClassN/A

Develop Information

Active CompaniesPikralida SP ZOO
Inactive CompaniesN/A
Active IndicationsEpilepsy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A